VACH

$11.67

Pre-MarketAs of Mar 17, 8:00 PM UTC

Voyager Acquisition Corp.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Recent News

Pharmaceutical Technology
Apr 23, 2025

Veraxa to go public in $1.6bn SPAC deal with Voyager

Veraxa Biotech will gain access to $253m in cash from Voyager to advance its cancer drug pipeline.

BEARISH
Negative press. News cycle fixated on risk factors or misses.